I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Park, Keunchil
506
results:
english X
Search for persons
X
Format
Online (506)
Mediatypes
Articles (Online) (374)
OpenAccess-fulltext (132)
Sorted by: Relevance
Sorted by: Year
?
1
Biomarker-directed targeted therapy plus durvalumab in adva..:
Besse, Benjamin
;
Pons-Tostivint, Elvire
;
Park, Keunchil
...
Nature Medicine. 30 (2024) 3 - p. 716-729 , 2024
Link:
https://doi.org/10.1038/..
?
2
A brief report on stable disease among amivantamab-treated ..:
Girard, Nicolas
;
Park, Keunchil
;
Lee, Se-Hoon
...
Cancer Treatment and Research Communications. 40 (2024) - p. 100832 , 2024
Link:
https://doi.org/10.1016/..
?
3
Comprehensive analysis of transcription factor-based molecu..:
Park, Sehhoon
;
Hong, Tae Hee
;
Hwang, Soohyun
...
eBioMedicine. 102 (2024) - p. 105062 , 2024
Link:
https://doi.org/10.1016/..
?
4
Avelumab Versus Platinum-Based Doublet Chemotherapy as Firs..:
Reck, Martin
;
Barlesi, Fabrice
;
Yang, James Chih-Hsin
...
Journal of Thoracic Oncology. 19 (2024) 2 - p. 297-313 , 2024
Link:
https://doi.org/10.1016/..
?
5
Real-World Efficacy and Safety of Amivantamab for EGFR-Muta..:
Wang, Kaiwen
;
Du, Robyn
;
Myall, Nathaniel J.
...
Journal of Thoracic Oncology. 19 (2024) 3 - p. 500-506 , 2024
Link:
https://doi.org/10.1016/..
?
6
Plain language summary of PAPILLON: amivantamab plus chemot..:
Sabari, Joshua K
;
Girard, Nicolas
;
Mansfield, Aaron S
...
Future Oncology. , 2024
Link:
https://doi.org/10.1080/..
?
7
Management of infusion-related reactions (IRRs) in patients..:
Park, Keunchil
;
Sabari, Joshua K.
;
Haura, Eric B.
...
Lung Cancer. 178 (2023) - p. 166-171 , 2023
Link:
https://doi.org/10.1016/..
?
8
A Phase 2 Study of Palbociclib for Recurrent or Refractory ..:
Jung, Hyun Ae
;
Kim, Miso
;
Kim, Hae Su
...
Journal of Thoracic Oncology. 18 (2023) 2 - p. 223-231 , 2023
Link:
https://doi.org/10.1016/..
?
9
CD73 Inhibitor Oleclumab Plus Osimertinib in Previously Tre..:
Kim, Dong-Wan
;
Kim, Sang-We
;
Camidge, D. Ross
...
Journal of Thoracic Oncology. 18 (2023) 5 - p. 650-656 , 2023
Link:
https://doi.org/10.1016/..
?
10
A plain language summary of the results from the group of p..:
Spira, Alexander
;
Girard, Nicolas
;
Krebs, Matthew
...
Future Oncology. 19 (2023) 33 - p. 2213-2225 , 2023
Link:
https://doi.org/10.2217/..
?
11
Whole-Section Landscape Analysis of Molecular Subtypes in C..:
Hwang, Soohyun
;
Hong, Tae Hee
;
Kim, Hong Kwan
...
Modern Pathology. 36 (2023) 7 - p. 100184 , 2023
Link:
https://doi.org/10.1016/..
?
12
Biomarker‐driven phase 2 umbrella trial: Clinical efficacy ..:
Park, Sehhoon
;
Kim, Yu Jung
;
Min, Young Joo
...
Cancer. 130 (2023) 4 - p. 541-552 , 2023
Link:
https://doi.org/10.1002/..
?
13
Efficacy and Safety of Ceritinib 450 mg/day with Food and 7..:
Cho, Byoung Chul
;
Kim, Dong-Wan
;
Batra, Ullas
...
Cancer Research and Treatment. 55 (2023) 1 - p. 83-93 , 2023
Link:
https://doi.org/10.4143/..
?
14
Expanded Access Program Pralsetinib in Advanced Non–Small C..:
Jeon, Youngkyung
;
Jung, Hyun Ae
;
Park, Sehhoon
...
Cancer Research and Treatment. 55 (2023) 4 - p. 1144-1151 , 2023
Link:
https://doi.org/10.4143/..
?
15
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mu..:
Cho, Byoung Chul
;
Kim, Dong-Wan
;
Spira, Alexander I.
...
Nature Medicine. 29 (2023) 10 - p. 2577-2585 , 2023
Link:
https://doi.org/10.1038/..
1-15